✦ LIBER ✦

Trials of neuroprotective therapies for Parkinson’s disease: Problems and limitations

✍ Scribed by Raúl de la Fuente-Fernández; Michael Schulzer; Edwin Mak; Vesna Sossi

Book ID: 116820783
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 179 KB
Volume: 16
Category: Article
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2010.04.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroprotective Therapy for Parkinson's

Neuroprotective Therapy for Parkinson's disease

✍ I.Shoulson and the Parkinson Study Group 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

In the context of degenerative disorders of the basal ganglia, neuroprotective therapy refers to interventions that preserve the integrity and function of vulnerable neurons and thereby slow or halt clinical decline. Decoppering therapy for Wilson's disease is the only established neuroprotective th

Neuroprotective Therapy for Parkinson's

Neuroprotective Therapy for Parkinson's Disease

✍ William C. Koller 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Neuroprotective strategies for Parkinson

Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials

✍ Wassilios Meissner; Michael P. Hill; François Tison; Christian E. Gross; Erwan B 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Biomarkers for trials of neuroprotection

Biomarkers for trials of neuroprotection in Parkinson's disease

✍ Pankaj A. Agarwal; A. Jon Stoessl 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 577 KB

Trial designs used to study neuroprotect

Trial designs used to study neuroprotective therapy in Parkinson's disease

✍ Anthony E. Lang; Eldad Melamed; Werner Poewe; Olivier Rascol 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

Recent advances in possible neuroprotect

Recent advances in possible neuroprotective and neurorestorative therapies for Parkinson's disease

✍ N. Ogawa 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 145 KB